Cargando…
SAT644 Gender Affirming Hormone Therapy (GHAT) In Adult Male-to-female Mice Increases Cortical And Trabecular Bone, Resulting In An Increase In Bone Strength
Disclosure: J.D. Zajac: None. T. Nie: None. V. Venkatesh: None. S. Golub: None. K. Stok: None. R. Desai: None. D.J. Handelsman: None. R.A. Davey: None. There are conflicting reports of the effects of GAHT on bone health and fracture risk in adult transgender women, and the underlying changes are poo...
Autores principales: | Zajac, Jeffrey D, Nie, Tian, Venkatesh, Varun, Golub, Suzanne, Stok, Kathryn, Desai, Reena, Handelsman, David J, Grossmann, Mathis, Davey, Rachel A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554799/ http://dx.doi.org/10.1210/jendso/bvad114.2093 |
Ejemplares similares
-
SAT413 Feminising Gender Affirming Hormone Therapy Prolongs QTc Interval
por: Angus, Lachlan, et al.
Publicado: (2023) -
SAT405 Bone Analysis Of Transgender Women Amateur Athletes Undergoing Gender-affirming Hormone Therapy
por: dos Santos, Lívia Marcela, et al.
Publicado: (2023) -
SAT409 Sublingual Estradiol Only, Compared To Combined Oral Estradiol And Cyproterone Acetate,Offers No Apparent Advantage For Gender Affirming Hormone Therapy (GHAT), In Treatment Naïve Transwomen: Results Of A Prospective Pilot Study
por: Yaish, Iris, et al.
Publicado: (2023) -
SAT647 Quantifying The Effects Of Gender-Affirming Hormone Therapy On Bone Density Of Transgender Patients: Emerging Results Of A Single-center Study
por: Godar, Cassandra M, et al.
Publicado: (2023) -
SAT399 Are Gender-affirming Hormone Therapy Duration And Body Mass Index Associated With Bone Mineral Density In Transgender And Gender Diverse Adults?
por: Iwamoto, Sean J, et al.
Publicado: (2023)